Expression of human glucocerebrosidase following retroviral vector-mediated transduction of murine hematopoietic stem cells
- PMID: 1768976
Expression of human glucocerebrosidase following retroviral vector-mediated transduction of murine hematopoietic stem cells
Abstract
The human glucocerebrosidase (GC) gene has been expressed in the progeny of murine hematopoietic stem cells following transduction of marrow with a retroviral vector (G2) containing the human GC cDNA. Murine marrow was transduced via co-cultivation following prestimulation in the presence or absence of recombinant IL-3 and IL-6. A high rate of gene transfer and expression (95%) was demonstrated in primary day 12 CFU-S foci following bone marrow transplantation (BMT) of G2-transduced marrow into lethally irradiated syngeneic recipient mice. Immunoreactive human GC protein was also documented in the CFU-S foci. Primary recipient mice were examined 4-6 months following BMT. A higher rate of gene transfer (87%) was seen in hematopoietic organs of recipients of prestimulated donor marrow compared with organs from initially unstimulated marrow (25%). A high rate of expression of human GC was also documented in the prestimulated organs (50%) when compared with the unstimulated group (25%). Secondary BMT was performed using marrow from the long-lived primary recipients. The human GC gene was present in 88% of secondary day 12 CFU-S foci examined in the prestimulated group versus 23% in the unstimulated group. Expression of the human GC gene was documented in secondary day 12 CFU-S foci, providing strong evidence of initial hematopoietic stem cell transduction.
Similar articles
-
Correction of the enzyme deficiency in hematopoietic cells of Gaucher patients using a clinically acceptable retroviral supernatant transduction protocol.Exp Hematol. 1994 Feb;22(2):223-30. Exp Hematol. 1994. PMID: 8299741
-
The presence of an autologous marrow stromal cell layer increases glucocerebrosidase gene transduction of long-term culture initiating cells (LTCICs) from the bone marrow of a patient with Gaucher disease.Gene Ther. 1995 Oct;2(8):512-20. Gene Ther. 1995. PMID: 8593601
-
Toward gene therapy for Gaucher disease.Hum Gene Ther. 1991 Summer;2(2):101-5. doi: 10.1089/hum.1991.2.2-101. Hum Gene Ther. 1991. PMID: 1911928
-
Prospects for human gene therapy.J Reprod Med. 1992 Jun;37(6):508-14. J Reprod Med. 1992. PMID: 1619603 Review.
-
Gene transfer into murine hematopoietic stem cells and bone marrow stromal cells.Ann N Y Acad Sci. 1990;612:398-406. doi: 10.1111/j.1749-6632.1990.tb24327.x. Ann N Y Acad Sci. 1990. PMID: 2291566 Review.
Cited by
-
Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models.Semin Hematol. 2013 Apr;50(2):101-30. doi: 10.1053/j.seminhematol.2013.03.025. Semin Hematol. 2013. PMID: 24014892 Free PMC article. Review.
-
Musings on genome medicine: enzyme-replacement therapy of the lysosomal storage diseases.Genome Med. 2009 Dec 9;1(12):114. doi: 10.1186/gm114. Genome Med. 2009. PMID: 20017892 Free PMC article.
-
Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow.J Clin Invest. 1992 Aug;90(2):342-8. doi: 10.1172/JCI115868. J Clin Invest. 1992. PMID: 1379609 Free PMC article.
-
Murine hematopoietic reconstitution after tagging and selection of retrovirally transduced bone marrow cells.Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13239-44. doi: 10.1073/pnas.94.24.13239. Proc Natl Acad Sci U S A. 1997. PMID: 9371830 Free PMC article.
-
Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector.Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11332-6. doi: 10.1073/pnas.89.23.11332. Proc Natl Acad Sci U S A. 1992. PMID: 1454816 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous